However, PD-L1 expression was not a significant biomarker for response to anti-PD-1 in HCC as evidenced by the findings from ICB trials CheckMate 040 and KEYNOTE-224 (20, 91). The gene discussed is CD274; the disease is hepatocellular carcinoma.